You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 10, October 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 60TH ANNUAL MEETING OF THE PACIFIC COAST SURGICAL ASSOCIATION, VANCOUVER, CANADA, FEBRUARY 22, 1989
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (43)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prognostic Significance of Pregnancy in Stage I Melanoma

Jan H. Wong, MD; Ernest E. Sterns, MD; Kelly H. Kopald, MD; J. Anne Nizze, PAC; Donald L. Morton, MD

Arch Surg. 1989;124(10):1227-1231.


Abstract

• The clinical course of 66 patients with stage I melanoma, diagnosed during pregnancy, treated in the Division of Surgical Oncology at UCLA, was retrospectively reviewed. These patients were compared with 619 nonpregnant female patients with melanoma. There was no significant difference between the pregnant population and control population with respect to location of the primary tumor, age at diagnosis, Clark's level, mean depth of invasion (pregnant females, 1.24 mm vs control, 1.28 mm), and histologic type. The 5-year survival for the women diagnosed with melanoma during pregnancy and for the entire population was 86% and 87%, respectively. These results demonstrate that women diagnosed with melanoma during pregnancy fare no worse than their nonpregnant counterparts. Criteria other than the theoretical effect of pregnancy on the tumor should be used to counsel patients diagnosed with melanoma during pregnancy.

(Arch Surg. 1989;124:1227-1231)



Author Affiliations

From the John Wayne Cancer Clinic, Armand Hammer Laboratories, Jonsson Comprehensive Cancer Center, UCLA (Drs Wong, Kopald, and Morton and Ms Nizze); the Surgical Service, Sepulveda (Calif) Veterans Administration Medical Center (Dr Wong); and the Department of Surgery, Queen's University, Kingston, Ontario (Dr Sterns).


Footnotes

Accepted for publication June 10, 1989.

Read before the 60th Annual Meeting of the Pacific Coast Surgical Association, Vancouver, Canada, February 22, 1989.

Reprint requests to Ninth Floor Factor Bldg, UCLA School of Medicine, Los Angeles, CA 90024 (Dr Wong).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fetal Microchimeric Cells Participate in Tumour Angiogenesis in Melanomas Occurring during Pregnancy
Nguyen Huu et al.
Am. J. Pathol. 2009;174:630-637.
ABSTRACT | FULL TEXT  

Effect of Pregnancy on Survival in Women With Cutaneous Malignant Melanoma
Lens et al.
JCO 2004;22:4369-4375.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.